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Dr. Robert K. Crane made major contributions to our understanding of carbohydrate
metabolism and transport of the intestine over a very long and productive career. This
Perspective examines, briefly, his early life and academic positions, but more importantly,
this Perspective highlights his contributions to the understanding of coupled Na+-glucose
absorption by the small intestine. I discuss how his early hypothesis of a “cotransport” of
sodium and glucose ushered in and provided the physiological explanation for the clinical
treatment of acute diarrhea and cholera when using oral rehydration therapy (ORT). ORT
saves millions of lives each year. Certainly, humankind is better off because of Crane’s
hypothesis of the Na+-glucose cotransporter that he put forth over 50 years ago?
Keywords: sodium-glucose cotransporter, SGLT1, diarrhea, cholera, oral rehydration therapy
OVERVIEW
I wish to start this Perspective with a few key questions. First,
how does onemeasure the impact of a hypothesis on humankind?
Secondly, how can one measure the impact of a simple idea which
through its contribution to medical science, “saves” millions of
lives each year? This all began with Crane’s theoretical calculations
for how sodium and glucose were transported across the cellu-
lar membranes of intestinal epithelial cells ∼10 years before the
structure of the cell membrane had been described (Singer and
Nicolson, 1972)!
The focus of this Perspective is to briefly highlight the life and
scientific contributions of Robert Kellogg Crane on the field of
carbohydrate transport in intestinal function and implications of
his work in the clinical treatment of acute diarrhea.
THE MAN AND HIS SCIENTIFIC PATH
Robert Kellogg Crane (1919–2010, Figure 1A) was born in
Palmyra, New Jersey to Wilbur Fiske Crane, Jr., and Mary
Elizabeth McHale Crane. His father was a highly regarded farm
building architect and engineer (Crane, 2010). Crane went to
public schools in Palmya and eventually graduated from St.
Andrew’s School inMiddletown, Delaware in 1938 (Crane, 2010).
Afterward, Crane entered Washington College in Chestertown,
Maryland. He graduated in 1942 with a B.S. in chemistry and a
double minor in biology and physics. Interestingly, Crane was not
all that excited about science when he entered college. However,
during his freshman year he had a change of heart, which he
himself attributed to lectures given by Kenneth Buxton which he
described as “compelling and complete” (Crane, 2010). After a
short time in the Navy, Crane began graduate school at Harvard
Medical School in the medical science program. While at Boston,
Crane studied biochemistry first with Eric Ball and then with
Fritz Lipmann (the latter in 1953 shared the Nobel Prize in
Physiology or Medicine for his discovery of co-enzyme A and
its importance for intermediary metabolism with Hans Krebs,
who discovered the citric acid cycle). Crane was awarded his
Ph.D. in 1950 (Crane, 2010) where upon he moved to Carl Cori’s
Department of Biological Chemistry at Washington University
School of Medicine in St. Louis. For the next 12 years whilst at
Washington University, Crane continued his research in carbohy-
drate metabolism (Crane, 2010). Prior to Crane’s arrival, in 1947,
Cori and his wife Gerty Cori, shared the Nobel Prize in Physiology
or Medicine for their discovery of the course of the catalytic con-
version of glycogen with Bernardo Houssay, jointly awarded for
his discovery of the part played by anterior pituitary lobe hor-
mone in the metabolism of sugar. Earl Sutherland (awarded in
1971 the Nobel Prize in Physiology or Medicine for his discover-
ies concerning the mechanisms of the action of hormones; and
instrumental in the discovery of cAMP) and Christian de Duve
(who in 1974 shared the Nobel Prize in Physiology or Medicine
with George Palade and Albert Claude for their discoveries con-
cerning the structural and functional organization of the cell)
were also working in Cori’s Department, with de Duve closely
working with the Coris’ as a visiting Rockefellar Foundation fel-
low (Christie and Tansey, 2000). After leaving St. Louis, Crane
was recruited as the Chairman of Biochemistry at the University
of Chicago, and after 4 years (1966), hemoved to be the Chairman
of Physiology at the new Rutgers Medical School (now known as
Robert Wood Johnson Medical School) where he remained until
he retired in 1986 (Crane, 2010). It was therefore not so surprising
that Crane, being surrounded by such illustrious scientists, was
destined for greatness. During his career, Crane published over
135 research and review papers. Today, a quick search in Google
Scholar determines that Crane’s h-Index is currently at 50.
Additional details of Dr. Crane’s college and work life up to
the early 1960s can be found in Crane (1983). Interested readers
are also directed to the following American Physiological Society
website http://the-aps.org/mm/Membership/Living-History/
Crane to view an interview with Dr. Crane and additional
information about him (Living History, 2010).
FINDING THE Na+-GLUCOSE COTRANSPORTER
In the early part of Crane’s career, he focused his research
on phosphate, CO2 fixation, hexokinase, glucose-6-phosphatase
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FIGURE 1 | A photo of Dr. Robert K. Crane and sketch of the
Na+-glucose cotransport model. (A) This is a photo of Dr. Crane in the
early 1960s. (B) This is the model of coupled Na+-glucose cotransport of
the small intestine. This is the hand-drawn model of the flux coupled
Na+-glucose cotransport which Crane sketched prior to delivering his talk at
the Symposium on Membrane Transport and Metabolism. It was this model
that was first shown at the meetings in Prague in 1960. (Photo of Crane
used with permission the Creative Commons Attribution 3.0 United States
(http://creativecommons.org/licenses/by/3.0/us/deed.en) license) (Photo of
the Na+-glucose cotransport model from “For Living History” from the
American Physiological Society website http://the-aps.org/mm/Membership/
Living-History/Crane).
biochemistry among other topics before he shifted into carbo-
hydrate biochemistry and transport (Crane, 1960). Nonetheless,
Crane was the first to champion the concept of the “cotransport
hypothesis” in coupling of glucose absorption with Na+ trans-
port for epithelial cells of the small intestine at international
meetings in Prague in 1960 (Crane, 1960, 2010; Crane et al.,
1961). As Crane described at that symposium on “Membrane
Transport and Metabolism” (Crane et al., 1961) and also found
in the Living History of Physiology at the American Physiological
Society webpage (given above); Crane stated:
“On August 24, 1960 in a lecture presented at Prague during a
Symposium on Membrane Transport and Metabolism I proposed
for the first time anywhere that the fluxes of an ion and a substrate
could be coupled by combining with the same reversible trans-
port carrier in the cell membrane. In the intestinal epithelial cells
that I was studying the ion was sodium and the substrate was glu-
cose. Because of the coupling, glucose accumulation to high levels
in the cells, i.e., active transport, was seen to be powered by the
ATP-driven efflux of sodium ions elsewhere.”
According to Crane (2010), the final thoughts of his model
were sketched quickly just prior to those meetings on what
appears to be a napkin (Figure 1B). It was this sketch that he
presented to the attendees of the symposium. Others in atten-
dance at the symposium were Peter Mitchell (awarded the 1978
Nobel Prize in Chemistry for his contribution to the understand-
ing of biological energy transfer through the formulation of the
chemiosmotic theory) and Jens Christian Skou who shared the
1997 Nobel Prize in Chemistry for his work for the first discov-
ery of an ion-transporting enzyme, Na+, K+ -ATPase, along with
Paul Boyer and JohnWalker for their elucidation of the enzymatic
mechanism underlying the synthesis of adenosine triphosphate
(ATP) (Christie and Tansey, 2000).
During the 1940s and 1950s, numerous research groups on
both sides of the Atlantic Ocean were working on carbohydrate
biochemistry, metabolism and transport including the transport
of glucose. These groups included David Fisher, Dennis Parson
and David Smyth to name a few whom were working at Sheffield
and Oxford and other institutions while Crane, Thomas Wilson
(HarvardUniversity) and others were working in the States. Many
substantial advances in our understanding of carbohydrate bio-
chemistry were made during this period. Interestingly, there was
a Witness Seminar held in 1999 at the Wellcome Institute for the
History of Medicine chaired by Professor Lord Leslie Turnberg
with notable players in the field of intestinal absorption being
present, including Richard Naftalin, Roy Levin, J. Ramsey Bronk,
Hermon Dowling and others. At that meeting, Richard Boyd
posed the question “Why wasn’t sodium-coupled glucose trans-
port discovered in the UK and, more specifically, why wasn’t it
discovered either in Sheffield or in Oxford?” He went on to state
“. . . Of course, the seminal work that led to our key modern
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view of how sodium-coupled glucose transport occurs was a
model drawn by R. K. Crane and colleagues . . ..” (The tran-
script of this meeting can be found in Christie and Tansey,
2000.)
As one reads the transcript of the 1999 meetings (Christie and
Tansey, 2000), it was surprising that Crane, though retired, was
not listed as a participant nor was he listed as one who sent apolo-
gies for not attending. Suffice to say, even in Crane’s absence, it
was duly noted and his work was rightly described as “seminal”!
Even though Crane proposed the Na+-glucose cotransport
hypothesis in 1960, 27 years were to elapse before in 1987 Wright
and colleagues cloned the protein predicted as the Na+-glucose
cotransporter, and later referred to as SGLT1 (Hediger et al.,
1987). Recently, Wright et al. (Faham et al., 2008) identified
the crystal structure of a related Na+-galactose cotransporter
(vSGLT) isolated from Vibrio parahaemolyticus, further validat-
ing Crane’s original predictions. The reader is directed for further
information concerning SGLT-1 and other human Na+-glucose
cotransporters to a recent comprehensive review by Wright et al.
(2011).
THE CELLULAR MODEL OF Na+-GLUCOSE ABSORPTION
The now “classical” model of Na+ and glucose absorption (Na+-
glucose co-transport) by the epithelial cells of the small intestine
is depicted in Figure 2. The entry step of glucose across the
luminal membrane is via the Na+-glucose cotransporter (SGLT1,
encoded by the SLC5A1 gene) and it is inhibited by phloridzin
(Ehrenkranz et al., 2005) (Figure 2). The driving force for this
transport protein is the Na+ electrochemical gradient that is gen-
erated and maintained by the basolateral Na+/K+-ATPase [Na+
pump; (Skou, 1957)] which is blocked by ouabain (Glynn, 1964).
Na+ transported into the cell exits across the basolateral cell
membrane via the weakly electrogenic Na+ pump (3Na+ out:
2K+ in) with intracellular K+ ions being recycled back across
the basolateral membrane via K+ channels. This mechanism
FIGURE 2 | Cellular model of the coupled Na+-glucose cotransporter.
The details of this cellular model are given in the text.
aids in the maintenance of the epithelial cell negative cellular
membrane potential facilitating Na+ entry across the luminal
membrane (Figure 2). The glucose transported by SGLT1 into
the cell is either metabolized or exits across the basolateral
membrane via facilitative glucose concentration gradient trans-
port via glucose transporter 2 (GLUT2, encoded by the SLC2A2
gene) (Augustin, 2010). The net movement of Na+ and glucose
across the intestinal epithelium contributes to a charge separa-
tion and a small osmotic gradient which provides the driving
forces for both Cl− absorption via the paracellular pathway, and
water absorption via both transcellular and paracellular path-
ways, separately (Figure 2). This physiological process results in
the overall transport of Na+, glucose, Cl−, and water; four key
substances needed to reduce the symptoms of acute diarrhea and
cholera.
CLINICAL IMPLICATIONS—THE Na+-GLUCOSE
CO-TRANSPORTER AND ORAL REHYDRATION THERAPY
Infectious diarrheal diseases including cholera have contributed
to hundreds of millions of deaths over the past few centuries,
of which, many are children under the age of five (Synder and
Merson, 1982; Taylor and Greenough, 1989). It was estimated in
1982 that there were more than 1 billion cases of acute diarrhea
world-wide with nearly five million deaths alone, in the younger
population (Synder andMerson, 1982). Ten years later, Bern et al.
(1992) reported that the number of cases of diarrhea was main-
tained at one billion, however, the number of under 5-year old
deaths was reduced to three million. In 2003, it was reported that
deaths for this age group had dropped to 2.5 million per year
(data from 1992–2000; Kosek et al., 2003). In closer examina-
tion for cholera alone, there have been eight pandemics of cholera
during the past 200 years (Guerrant et al., 2003). In July 2012,
the World Health Organization (WHO) estimated that there are
3–5 million cases of cholera each year with only 100,000–120,000
deaths (WHO, 2012). What has caused the incredible reduction
in the death rate for individuals contracting diarrhea? The “magic
bullet” has been the world wide employment of oral rehydration
therapy (ORT).
There is great controversy as to whom made the greatest con-
tribution to the discovery and use of ORT in part because early
therapies which were effective, were not based on scientific dis-
covery but, rather on folklore and natural remedies. Such reme-
dies which included the ingestion of a mixture of molasses and
rock salt, maize, yams, rice water, coconut juice, green bananas
(among other natural products) have been recorded during the
past 3000 years and used to reduce the loss of water from the body
(Rao, 2004) and therefore alleviating the symptoms of diarrhea.
While ORT stumbled around in the dark for many years there
were a number of scientific “kingpins” in the nineteenth cen-
tury who actively contributed to our scientific knowledge. Of
these, O’Shaughnessy (1831) was one of the early pioneers who
attempted to not only treat but understand the scientific basis
of watery diarrheas, observing that patients with such ailments
as exhibiting excessive loss of salt and water in the stool. He
posited that the dehydration and changes in blood chemistry
of patients with cholera, which mimicked those seen for yellow
fever, could be better treated by giving patients intravenous salt
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and water as a remedy. He was one of the first to try and explain
why the ingestion of weak alkali salts with or without starches
in tepid water, was effective. A phenomenon he attributed to
a cleansing of the blood. Early investigations into the infec-
tious disease basis for cholera were made a short time later by
Dr. Jack Snow during the 1850s, who first attributed the spread
of cholera to a problem with the drinking water supply by plot-
ting patient deaths with distances from drinking water wells in
London (Snow, 1855; Schultz, 2007). While the later findings
certainly advanced our understanding of the need for water clean-
liness and sanitation it was not until the 1940s, that D. C. Darrow
(a pediatrician) refocused the attention of many within the sci-
entific field on the fact that understanding the exact changes
in the ionic composition of body fluids in patients with infan-
tile diarrhea would be paramount for the successful treatment
of the disease (Darrow et al., 1949). Captain Robert Phillips led
the fight against the 1961 pandemic of cholera in the Philippines
(Phillips, 1963). He used a solution that was composed of a low
sodium electrolyte that was “isosmolar” and that he used glu-
cose as a non-electrolyte to replace the reduced sodium (Ruxin,
1994), therefore, some credit Phillips to be the first individual to
use an ORT-type approach. He was awarded the Albert Lasker
Medical Research Award in 1967, the United States’ preeminent
medical award, for “. . . his contributions to the understanding
of the mechanism of death in cholera, and the development of a
life-saving method of treating it” (Phillips, 1967; Savarino, 2002).
During the 1950s many biochemists and physiologists were study-
ing the properties of carbohydrate transport of the mammalian
intestine. Fisher and Parsons (1950, 1953) examined transport
properties of glucose across the rat small intestine in early 1950s.
Riklis and Quastel (1958), some say, lead the way in under-
standing the importance of sodium in the active transport of
glucose by the guinea pig intestine (Ruxin, 1994). While, work
by Wilson and Crane (1958) and Crane and Krane (1959) helped
explain the mechanism of active transport of glucose and the
need for the presence of sodium. Finally, Schultz and Zalusky
(1964a,b), using Ussing chambers and the short-circuit current
technique, examined the Na+ fluxes, short-circuit current, trans-
mural potential difference and glucose transport of the isolated
rabbit ileum. All of these individuals, and many more who have
not been highlighted here, have made major contributions to our
understanding of Na+ and glucose transport across the intestinal
epithelium and their work laid the firm foundation for ORT.
FINAL THOUGHTS
So, how does Crane’s contribution of the Na+-glucose cotrans-
porter “fit” in with the development of ORT?Well, this is actually
a complicated question. There is no doubt that Crane’s model is
the basis of the cellular mechanism of Na+-glucose absorption by
the small intestine. Indeed, the Na+-glucose cotransporter is the
“heart” of the cellular model and of the successful use of ORT.
Without the Na+-glucose cotransporter there would be no ORT,
and thus, there would of been hundreds of millions of people who
would not have led a full life. So, I am drawn back to the words of
Richard Boyd who described Crane’s work as “seminal.”
It is obvious that Crane made major contributions to the
field of carbohydrate metabolism and transport. I will end this
Perspective with a quote that has been repeated in science lit-
erature and in the popular press “. . . the discovery that sodium
transport and glucose transport are coupled in the small intes-
tine, so that glucose accelerates absorption of solute and water,
was potentially the most important medical advance this cen-
tury [20th century]. . . (The Lancet, 1978).” Certainly, this is an
appropriate testimony to the memory of Robert Kellogh Crane.
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